FX.co ★ USANA Health Sciences Reports Decline In Q3 Income, But Beats Estimates

USANA Health Sciences (USNA) has announced its third-quarter earnings, revealing a decline compared to the previous year but surpassing Wall Street predictions. The company reported a net income of $10.61 million, translating to earnings of $0.56 per share. This is a decrease from last year’s third-quarter figures of $11.35 million, or $0.59 per share.

According to data from Thomson Reuters, analysts had forecasted earnings of $0.48 per share, with estimates excluding special items.

The quarter saw a 6.2% drop in revenue, which fell to $200.22 million from $213.37 million in the same period last year.

Key third-quarter performance highlights for USANA Health Sciences (GAAP) include:

- Earnings: $10.61 million, compared to $11.35 million the previous year.

- Earnings per Share (EPS): $0.56, compared to $0.59 last year.

- Revenue: $200.22 million, down from $213.37 million a year ago.

Outlook: The company has set its full-year EPS guidance at $2.45 and projects full-year revenue to reach $850 million.